BCAL California BanCorp \ CA (BCAL) Insider Trading, Ownership & Congress Trades
Banks · National commercial banks · CIK 0001795815
Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $97.2K priced
What the filings say about BCAL
Insiders, 180 days
-$1.9M net sold
1 buyer · 3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$158.9K
1 notice
California BanCorp \ CA insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, California BanCorp \ CA insiders sold a net $1.9M of stock across 8 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 18.9% of the 2,377 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Muller Frank L. bought about $10.0K of BCAL on Sep 4, 2026.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 20, 2024.
- The trade is 33.5% of the 22,390 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Machado Lester sold about $158.9K of BCAL on Jul 31, 2026.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 23.3% of the 72,935 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: President Hernandez Richard sold about $325.0K of BCAL on May 8, 2026; 1 other insider sold within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 21.0% of the 356,347 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Executive Chairman Rainer David I sold about $1.4M of BCAL on May 7, 2026; 1 other insider sold within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 21.5% of the 37,174 shares held after it.
- No other insider sold within 30 days.
Insider activity: Bank Chief Financial Officer Carandang Jean sold about $143.2K of BCAL on Mar 6, 2026.8 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.9M over 180 days
-$149.0K over 90 days
below 80% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
$9.4M repurchased, FY to 2026-06-30
more than 54% of Banks
Short interest
4.3% of the float short (float per yahoo 2026-10-26) · 3.8 days to cover · settled 2026-09-30
more than 53% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch BCAL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+32.9%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns BCAL: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in BCAL
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
BCAL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Machado Lester
Filed 2026-08-12
$158.9K
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.9M sold by insiders over 180 days, $158.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
BCAL financials
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM BCAL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM BCAL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Free cash flow, TTM
$59.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BCAL
| FY Dec 2025 | $56.9M |
| FY Dec 2024 | $49.7M |
| FY Dec 2023 | $32.8M |
| FY Dec 2022 | $12.3M |
| Jun 2026 | $14.3M |
| Mar 2026 | $8.3M |
| Dec 2025 | $20.8M |
| Sep 2025 | $15.9M |
| Jun 2025 | $13.4M |
| Mar 2025 | $6.9M |
| Dec 2024 | $23.5M |
| Sep 2024 | $18.1M |
At each fiscal year end
Single quarter
Debt to equity
0.06x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity BCAL
| FY Dec 2025 | 0.06x |
| FY Dec 2024 | 0.14x |
| FY Dec 2023 | 0.36x |
| FY Dec 2022 | 0.26x |
| Jun 2026 | 0.06x |
| Mar 2026 | 0.06x |
| Dec 2025 | 0.06x |
| Sep 2025 | 0.06x |
| Jun 2025 | 0.10x |
| Mar 2025 | 0.13x |
| Dec 2024 | 0.14x |
| Sep 2024 | 0.14x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.74x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt BCAL
| FY Dec 2025 | 1.69x |
| FY Dec 2024 | 0.72x |
| FY Dec 2023 | 0.32x |
| FY Dec 2022 | 0.20x |
| Jun 2026 | 1.74x |
| Mar 2026 | 1.72x |
| Dec 2025 | 1.69x |
| Sep 2025 | 1.79x |
| Jun 2025 | 1.18x |
| Mar 2025 | 0.70x |
| Dec 2024 | 0.72x |
| Sep 2024 | 0.26x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BCAL
| FY Dec 2025 | +11.6% |
| FY Dec 2024 | +1.4% |
| FY Dec 2023 | +9.4% |
| FY Dec 2022 | +6.4% |
| Jun 2026 | +10.6% |
| Mar 2026 | +10.8% |
| Dec 2025 | +11.6% |
| Sep 2025 | +11.9% |
| Jun 2025 | +7.4% |
| Mar 2025 | +4.2% |
| Dec 2024 | +1.4% |
| Sep 2024 | -1.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BCAL
| FY Dec 2025 | +1.6% |
| FY Dec 2024 | +0.2% |
| FY Dec 2023 | +1.1% |
| FY Dec 2022 | +0.7% |
| Jun 2026 | +1.5% |
| Mar 2026 | +1.5% |
| Dec 2025 | +1.6% |
| Sep 2025 | +1.5% |
| Jun 2025 | +1.0% |
| Mar 2025 | +0.6% |
| Dec 2024 | +0.2% |
| Sep 2024 | -0.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BCAL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BCAL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.86x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BCAL
| FY Dec 2025 | 9.62x |
| FY Dec 2024 | 38.47x |
| FY Dec 2023 | 12.48x |
| FY Dec 2022 | 19.12x |
| Jun 2026 | 11.26x |
| Mar 2026 | 9.63x |
| Dec 2025 | 9.62x |
| Sep 2025 | 7.65x |
| Jun 2025 | 14.20x |
| Mar 2025 | 20.77x |
| Dec 2024 | 38.47x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$475.4M
market value at close 2026-10-27 on 2026-08-04 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value BCAL
| FY Dec 2025 | $237.4M |
| FY Dec 2024 | $213.6M |
| FY Dec 2023 | $333.9M |
| FY Dec 2022 | n/a |
| Jun 2026 | $440.0M |
| Mar 2026 | $195.9M |
| Dec 2025 | $237.4M |
| Sep 2025 | $16.6M |
| Jun 2025 | $133.6M |
| Mar 2025 | $95.4M |
| Dec 2024 | $213.6M |
| Sep 2024 | -$271.0M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.4%
TTM free cash flow over market value at close 2026-10-27
FCF yield BCAL
| FY Dec 2025 | +9.4% |
| FY Dec 2024 | +9.3% |
| FY Dec 2023 | +10.3% |
| FY Dec 2022 | n/a |
| Jun 2026 | +8.8% |
| Mar 2026 | +10.2% |
| Dec 2025 | +9.4% |
| Sep 2025 | +11.0% |
| Jun 2025 | +12.1% |
| Mar 2025 | +10.5% |
| Dec 2024 | +9.3% |
| Sep 2024 | +6.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.18x
P/E over trailing EPS growth of 67%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing BCAL
| FY Dec 2025 | 0.03x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.22x |
| FY Dec 2022 | n/a |
| Jun 2026 | 0.17x |
| Mar 2026 | 0.06x |
| Dec 2025 | 0.03x |
| Sep 2025 | n/a |
| Jun 2025 | 0.49x |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Net income | $63.1M | $5.4M | $25.9M | $16.1M |
| EPS (diluted) | 1.93 | 0.22 | 1.39 | 0.88 |
| Operating cash flow | $57.3M | $50.3M | $33.1M | $13.4M |
| Cash | $399.9M | $388.2M | $86.8M | $86.8M |
| Long-term debt | $33.8M | $69.7M | $102.9M | $67.8M |
| Buybacks | $3.4M | $0 | $889.0K | $574.0K |
| Dividends paid | $3.3M | $0 | n/a | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
BCAL Stock Sonar score 4/7 axes
Find similar shapesCompareBCAL ranks highest on financial health (80th percentile) and profitability (68th), and lowest on insider conviction (33rd), among Banks peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BCAL filings, in plain words
Are California BanCorp \ CA insiders buying or selling BCAL?
In the 180 days to 2026-10-28, California BanCorp \ CA insiders were net sellers, a net $1.9M: $10.0K of purchases and $1.9M of sales reported on Form 4, by 1 buyer and 3 sellers.
Are there planned insider sales of BCAL?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $158.9K of stock; the latest, by Machado Lester, was filed 2026-08-12.
Read the full summary
In the 180 days to 2026-10-28, California BanCorp \ CA insiders were net sellers of BCAL, a net $1.9M across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Sales outweighed purchases more than tenfold by value. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $158.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
